Supp Fig 1_2_3_Hoban et al - Nature

1 downloads 0 Views 614KB Size Report
Olig1. Re la tiv e m. RN. A le v e ls. (A. U) h i g f. CON. GF. exGF. Figure S2: mRNA expression levels of myelin component and upstream myelin regulatoryĀ ...
Supplementary figure 1: Experimental flow chart Figure 1. RNA Sequencing

CON

Cohort 1 n=12 per group males only

Figure 2. qRT-PCR

xGF

GF

n=12 per group males only

Additional brain regions collected

Prefrontal Cortex Dissection

Total RNA Extraction

Total RNA Extraction Pooling n=4 per group Randomized

cDNA synthesis

Sample Pooling n=12 per group

Illumina RNA Sequencing

CON

GF

PFC qRT-PCR validations males n=12 per group

Randomized pooling of male PFC samples

RNA Sequencing n=4 per group

CON

n=3 per group males only

xGF

GF

Animal sacrifice and perfusion

Total Protein extraction/concentraion determined

Post fixation sectioning and imaging

Minimum 50 axons per animal measured

Western Blot and analysis

g-ratio analysis

Animal Cohort 2

Additional female cohort n=12 per group Sfig.2

Brain region dissection (6 regions per animal)

Figure 3 . TEM

Cohort 2

n=7 per group randomly selected

Functional annotation of differentially expressed genes (GO-Terms & KEGG pathways)

12 animals per group male only

qRT-PCR- based expression analysis for myelin component and regulatory genes

Figure 4. Western Blot

Differential gene expression analysis

Animal Cohort 1

xGF

GF

CON

Other brain regions for qRT-PCR analysis males only n=12 per group

PFC dissection males only n=3 per group

TEM g-ratio analysis

Randomized selection of PFC samples for Protein extraction males only

Western Blot n=7 per group

Figure S1: Experimental flowchart. Graphic al depiction of the animal number and usage for each individual experiment. Each Panel represents the outcome of tissue used for each of the individual main figure.

Supplementary figure 2: Female mice

0.5

0.0

CON

n.s. 1.0

0.5

CON

GF

ex-GF

n.s. 1.0

0.5

0.0

CON

GF

1.0

0.5

0.0

CON

ex-GF

GF

ex-GF

n.s. 1.0

0.5

0.0

CON

GF

1.0

0.5

CON

GF

0.5

0.0

CON

GF

ex-GF

ex-GF

Egr2 1.5

*

1.0

0.5

0.0

CON

i

n.s.

0.0

1.0

ex-GF

Sox10

1.5

n.s.

1.5

f

1.5

h

Sox2

1.5

n.s.

Plp1 Relative mRNA levels (AU)

1.5

0.0

1.5

e

Mobp

g Relative mRNA levels (AU)

ex-GF

Relative mRNA levels (AU)

Relative mRNA levels (AU)

d

GF

Mbp Relative mRNA levels (AU)

1.0

exGF

c

Relative mRNA levels (AU)

n.s.

Relative mRNA levels (AU)

RelativeMog mRNA levels (AU) Relative mRNA levels (AU)

1.5

Mag

b

GF

Relative mRNA levels (AU)

Mog

a

CON

GF

ex-GF

Olig1

1.5

n.s. 1.0

0.5

0.0

CON

GF

ex-GF

Figure S2: mRNA expression levels of myelin component and upstream myelin regulatory genes in the PFC of female CON, GF and exGF mice. No male-equiv alent changes in myelin component mRNA levels were found in the PFC of female GF and exGF mic e. (a-i) qRT-PCR of myelin component gene transcript and myelin regulating transcription factors in the PFC. Bar graphs indicate average values of 12 animals after š¯›½ -actin normalization relative to average control levels (p0.05; n=3 animals per group; n=>50 axons per animal (CON n=187 axons; GF n=390 axons).